Literature DB >> 27793646

6 HCV genotyping 9G test and its comparison with VERSANT HCV genotype 2.0 assay (LiPA) for the hepatitis C virus genotyping.

Wasun Chantratita1, Keum-Soo Song2, Choi GunHo3, Viroj Pongthanapisith4, Nipa Thongbaiphet5, Garanyuta Wongtabtim6, Ekawat Pasomsub7, Kanokwan Angkanavin8, Satish Balasaheb Nimse9, Mukesh Digambar Sonawane10, Shrikant Dasharath Warkad11, Taisun Kim12.   

Abstract

In this article, we describe the 6 HCV Genotyping 9G test and its evaluation by using clinical samples and plasmid DNA standards. In tests with 981 plasmid DNA standards, the 6 HCV Genotyping 9G test showed higher than 92.5% sensitivity and 99.4% specificity. The 6 HCV Genotyping 9G test was compared with the VERSANT HCV Genotype 2.0 assay (LiPA 2.0) for detection and discrimination of HCV genotypes in clinical samples. The results of both tests were verified by genomic sequencing. The 6 HCV Genotyping 9G test demonstrated a 100% agreement with the sequencing results, which was higher than LiPA 2.0. These results indicate that the 6 HCV Genotyping 9G test can be a reliable, sensitive, and accurate diagnostic tool for the correct identification of HCV genotypes in clinical specimens. 6 HCV Genotyping 9G test can genotype six HCV types in 1 PCR in 30min after PCR amplification. The 6 HCV Genotyping 9G test, thus provide critical information to physicians and assist them to apply accurate drug regimen for the effective hepatitis C treatment. Copyright Â
© 2016 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  9G DNA technology; HCV genotyping; Hcv; Hepatocellular carcinoma; LiPA 2.0; Liver cirrhosis

Mesh:

Substances:

Year:  2016        PMID: 27793646     DOI: 10.1016/j.jviromet.2016.10.009

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  4 in total

1.  Discrepancy between Hepatitis C Virus Genotypes and NS4-Based Serotypes: Association with Their Subgenomic Sequences.

Authors:  Nan Nwe Win; Shingo Nakamoto; Tatsuo Kanda; Hiroki Takahashi; Azusa Takahashi-Nakaguchi; Shin Yasui; Masato Nakamura; Shuang Wu; Fumio Imazeki; Shigeru Mikami; Osamu Yokosuka; Tohru Gonoi; Hiroshi Shirasawa
Journal:  Int J Mol Sci       Date:  2017-01-17       Impact factor: 5.923

2.  NS3 genomic sequencing and phylogenetic analysis as alternative to a commercially available assay to reliably determine hepatitis C virus subtypes 1a and 1b.

Authors:  Karin Neukam; Alfredo P Martínez; Andrés C A Culasso; Ezequiel Ridruejo; Gabriel García; Federico A Di Lello
Journal:  PLoS One       Date:  2017-07-28       Impact factor: 3.240

Review 3.  HCV Detection, Discrimination, and Genotyping Technologies.

Authors:  Shrikant Dashrath Warkad; Satish Balasaheb Nimse; Keum-Soo Song; Taisun Kim
Journal:  Sensors (Basel)       Date:  2018-10-12       Impact factor: 3.576

4.  Performance of 6 HCV genotyping 9G test for HCV genotyping in clinical samples.

Authors:  Shrikant Dasharath Warkad; Satish Balasaheb Nimse; Keum-Soo Song; Wasun Chantratita; Viroj Pongthanapisith; Laxman Uddhav Nawale; Taisun Kim
Journal:  Virol J       Date:  2018-07-11       Impact factor: 4.099

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.